ELIZABETH RAYNOR: Open Payments
NPI 1548638695 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 59 payments from 13 companies in 2025. Trend: 2023 $57 · 2024 $409 · 2025 $847
Food & beverage: $838Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $199 |
| ABBVIE INC. | 17 | $195 |
| Lilly USA, LLC | 11 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| PFIZER INC. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: VRAYLAR, MOUNJARO, Wegovy, Ozempic, CAPLYTA, HETLIOZ, LINZESS, ELIQUIS.
Industry payments across SC — which companies pay providers there.
